STARD4 and hepatocellular carcinoma: Results from quantitative reverse transcription PCR and western blotting indicated that the designed siRNA against STARD4 (si-STARD4) or overexpression plasmid (LV-STARD4) could effectively knock down or enhance the mRNA and protein levels of STARD4 in HCC cells (Fig. S1A–D).